Previous 10 | Next 10 |
Neos Therapeutics, Inc. (NEOS) Q2 2019 Earnings Conference Call August 08, 2019, 08:30 AM ET Company Participants Jerry McLaughlin - CEO Richard Eisenstadt - CFO Conference Call Participants Carvey Leung - Cantor Fitzgerald Ken Cacciatore - Cowen & Company Jason Butle...
Neos Therapeutics (NASDAQ: NEOS ): Q2 GAAP EPS of -$0.08 beats by $0.09 . More news on: Neos Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
– Company to host conference call today at 8:30am EDT – DALLAS and FORT WORTH, Texas, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and m...
Admittedly, I was once a short-term shareholder of Neos Therapeutics ( NEOS ), just prior to the company rejecting a $10.25 a share buyout offer from PDL Pharma back in 2017. I entered a position after Cotempla’s FDA approval in June and I was convinced I was investing in a strong ADH...
DALLAS and FORT WORTH, Texas, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally...
DALLAS and FORT WORTH, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally...
DALLAS and FORT WORTH, Texas, May 30, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally ...
Neos Therapeutics, Inc. (NEOS) Q1 2019 Earnings Conference Call May 9, 2019 8:30 AM ET Company Participants Jerry McLaughlin - Chief Executive Officer Richard Eisenstadt - Chief Financial Officer Conference Call Participants Carvey Leung - Cantor Fitzgerald Jason Butler - J...
DALLAS and FORT WORTH, Texas, May 09, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally ...
DALLAS and FORT WORTH, Texas, May 02, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally ...
News, Short Squeeze, Breakout and More Instantly...
Neos Therapeutics Inc. Company Name:
NEOS Stock Symbol:
NASDAQ Market:
Neos Therapeutics Inc. Website:
Penny Stock News Triggers Momentum In These Cheap Stocks When it comes to penny stocks, there are plenty of different catalysts to consider. You could look for general market trends or sector/industry-based themes. However, these are more along the line of technical catalysts. On the ot...
– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time – – Stockholders are encouraged to vote, no matt...
– The Neos Therapeutics Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 18, 2021 at 10:00 a.m. Eastern Time – – Stockholders are encouraged to vote, no matt...